Astrana Health Inc (STU:3AM) Stock Price, Trades & News

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.45
Equity-to-Asset	0.34
Debt-to-Equity	1.33
Debt-to-EBITDA	6.54
Interest Coverage	1.47
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.72	Distress Grey Safe
Beneish M-Score	-2.26	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	37
	3-Year EBITDA Growth Rate	3.7
	3-Year EPS without NRI Growth Rate	17.4
	3-Year FCF Growth Rate	17.7
	3-Year Book Growth Rate	11
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	71.07
	Future 3-5Y Total Revenue Growth Rate Estimate	13.82

Momentum Rank

9/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	94.57
	9-Day RSI	87.59
	14-Day RSI	82.09
	3-1 Month Momentum %	54.81
	6-1 Month Momentum %	50.47
	12-1 Month Momentum %	56.31

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.35
	Quick Ratio	1.35
	Cash Ratio	0.64
	Days Sales Outstanding	37.53
	Days Payable	13.44

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-1.6
	Shareholder Yield %	-20.08

Profitability Rank

7/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	10.66
	Operating Margin %	2.45
	Net Margin %	0.86
	EBITDA Margin %	4.62
	FCF Margin %	4.43
	OCF Margin %	4.74
	ROE %	3.91
	ROA %	1.58
	ROIC %	3.61
	3-Year ROIIC %	-0.65
	ROC (Joel Greenblatt) %	144.97
	ROCE %	8
	Years of Profitability over Past 10-Year	7
	Moat Score	3
	Tariff Resilience Score	8

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	73.8
	Forward PE Ratio	26.21
	PE Ratio without NRI	30.15
	Shiller PE Ratio	94.6
	Price-to-Owner-Earnings	22.77
	PEG Ratio	1.33
	PS Ratio	0.63
	PB Ratio	2.75
	Price-to-Free-Cash-Flow	14.31
	Price-to-Operating-Cash-Flow	13.37
	EV-to-EBIT	23.94
	EV-to-Forward-EBIT	9.83
	EV-to-EBITDA	15.95
	EV-to-Forward-EBITDA	8.2
	EV-to-Revenue	0.74
	EV-to-Forward-Revenue	0.67
	EV-to-FCF	16.75
	Price-to-GF-Value	0.55
	Price-to-Projected-FCF	1.75
	Price-to-Median-PS-Value	0.53
	Earnings Yield (Greenblatt) %	4.18
	FCF Yield %	6.94

Financials (Next Earnings Date:2026-08-07 Est.)

Annual Quarterly TTM

STU:3AM's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Astrana Health Inc Executives

Details

GF Value™: €72.06

STU:3AM

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with 3AM. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	3,028.832
	EPS (TTM) (€)	0.527
	Beta	1.0922
	3-Year Sharpe Ratio	0.26
	3-Year Sortino Ratio	0.43
	Volatility %	62.31
	14-Day RSI	82.09
	14-Day ATR (€)	1.179461
	20-Day SMA (€)	34.35
	12-1 Month Momentum %	56.31
	52-Week Range (€)	15.2 - 39.4
	Shares Outstanding (Mil)	49.58

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	4
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Astrana Health Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Astrana Health Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-06 17:30	In 129 days
Third quarter earnings results for 2026	2026-11-06	In 128 days
Second quarter earnings conference call for 2026	2026-08-07 17:30	In 38 days
Second quarter earnings results for 2026	2026-08-07	In 37 days
General meeting for 2026	2026-06-10 10:00	33.20 (+0.61%)
46th annual william blair growth stock conference	2026-06-03 16:00	31.60 (-1.86%)
Guidance call for 2026	2026-05-12 18:40	33.40 (+0.60%)
First quarter earnings conference call for 2026	2026-05-07 17:30	30.00 (+0.67%)
First quarter earnings results for 2026	2026-05-07	30.00 (+0.67%)
Oppenheimer 36th Annual MedTech & Services Conference	2026-03-18	21.40 (+0.94%)

Show

Entries

Astrana Health Inc Frequently Asked Questions

What is Astrana Health Inc(STU:3AM)'s stock price today?

The current price of STU:3AM is €40.60. The 52 week high of STU:3AM is €39.40 and 52 week low is €15.20.

When is next earnings date of Astrana Health Inc(STU:3AM)?

The next earnings date of Astrana Health Inc(STU:3AM) is 2026-08-07 Est..

Does Astrana Health Inc(STU:3AM) pay dividends? If so, how much?

Astrana Health Inc(STU:3AM) does not pay dividend.

Press Release

	Subject	Date
	Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth	2026-06-04
	Astrana Health, Inc. Announces Appointment of Interim National Medical Director	2026-05-12
	Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call	2026-04-21
	Astrana Health, Inc. to Participate in Upcoming Investor Conferences	2026-04-10
	Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades	2026-03-11
	Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results	2026-03-02
	Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call	2026-01-26
	Astrana Health, Inc. to Participate in Upcoming Investor Conference	2026-01-06
	Astrana Health, Inc. Reports Third Quarter 2025 Results	2025-11-06
	Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call	2025-10-15

10/Page

Articles on Astrana Health Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.